A validated and standardized pseudotyped microneutralization assay as a safe and powerful tool to measure LASSA virus neutralising antibodies for vaccine development and comparison [version 2; peer review: 2 approved]

Background Over the past few decades, World Health Organization (WHO) has made massive efforts to promote the development of a vaccine against Lassa virus (LASV), one of the top ten priority pathogens for research and development under the WHO R&D Blueprint for Emerging Infections. To date, seve...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:F1000Research
المؤلفون الرئيسيون: Alessandro Manenti, Emanuele Montomoli, Francesca Dapporto, Maria Altamura, Nigel Temperton, Pietro Piu, Claudia Semplici, Eleonora Molesti, Vittoria Forconi, Roberta Antonelli
التنسيق: مقال
اللغة:الإنجليزية
منشور في: F1000 Research Ltd 2024-10-01
الموضوعات:
الوصول للمادة أونلاين:https://f1000research.com/articles/13-534/v2

مواد مشابهة